Literature DB >> 20407062

Does this patient with diabetes have large-fiber peripheral neuropathy?

Jamil N Kanji1, Rebecca E S Anglin, Dereck L Hunt, Akbar Panju.   

Abstract

CONTEXT: Diabetic peripheral neuropathy predisposes patients to foot ulceration that heals poorly and too often leads to amputation. Large-fiber peripheral neuropathy (LFPN), one common form of diabetic neuropathy, when detected early prompts aggressive measures to prevent progression to foot ulceration and its associated morbidity and mortality.
OBJECTIVE: To systematically review the literature to determine the clinical examination findings predictive of asymptomatic LFPN before foot ulceration develops. DATA SOURCES, STUDY SELECTION, AND DATA EXTRACTION: MEDLINE (January 1966-November 2009) and EMBASE (1980-2009 [week 50]) databases were searched for articles on bedside diagnosis of diabetic peripheral neuropathy. Included studies compared elements of history or physical examination with nerve conduction testing as the reference standard. DATA SYNTHESIS: Of 1388 articles, 9 on diagnostic accuracy and 3 on precision met inclusion criteria. The prevalence of diabetic LFPN ranged from 23% to 79%. A score greater than 4 on a symptom questionnaire developed by the Italian Society of Diabetology increases the likelihood of LFPN (likelihood ratio [LR], 4.0; 95% confidence interval [CI], 2.9-5.6; negative LR, 0.19; 95% CI, 0.10-0.38). The most useful examination findings were vibration perception with a 128-Hz tuning fork (LR range, 16-35) and pressure sensation with a 5.07 Semmes-Weinstein monofilament (LR range, 11-16). Normal results on vibration testing (LR range, 0.33-0.51) or monofilament (LR range, 0.09-0.54) make LFPN less likely. Combinations of signs did not perform better than these 2 individual findings.
CONCLUSIONS: Physical examination is most useful in evaluating for LFPN in patients with diabetes. Abnormal results on monofilament testing and vibratory perception (alone or in combination with the appearance of the feet, ulceration, and ankle reflexes) are the most helpful signs.

Entities:  

Mesh:

Year:  2010        PMID: 20407062     DOI: 10.1001/jama.2010.428

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  15 in total

1.  Vibration perception threshold in the screening of sensorimotor distal symmetric polyneuropathy: the need of more accurate age-specific reference values.

Authors:  Laura Maffei; Valeria Premrou; Patricia Roldan; Massimiliano Copetti; Fabio Pellegrini; Maria Chiara Rossi; Giacomo Vespasiani
Journal:  J Diabetes Sci Technol       Date:  2014-03-27

2.  Cardiac autonomic function in children with type 1 diabetes.

Authors:  Kotb Abbass Metwalley; Sherifa Ahmed Hamed; Hekma Saad Farghaly
Journal:  Eur J Pediatr       Date:  2018-03-02       Impact factor: 3.183

3.  Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.

Authors:  Giuseppe Penno; Eleonora Russo; Monia Garofolo; Giuseppe Daniele; Daniela Lucchesi; Laura Giusti; Veronica Sancho Bornez; Cristina Bianchi; Angela Dardano; Roberto Miccoli; Stefano Del Prato
Journal:  Diabetologia       Date:  2017-03-29       Impact factor: 10.122

Review 4.  Distal Symmetric Polyneuropathy: A Review.

Authors:  Brian C Callaghan; Raymond S Price; Eva L Feldman
Journal:  JAMA       Date:  2015-11-24       Impact factor: 56.272

5.  Accuracy of the Neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetes.

Authors:  Nikolaos Papanas; Paschalis Paschos; Dimitrios Papazoglou; Konstantinos Papatheodorou; Konstantinos Paletas; Efstratios Maltezos; Apostolos Tsapas
Journal:  Diabetes Care       Date:  2011-04-19       Impact factor: 19.112

6.  Determinants of Slow Walking Speed in Ambulatory Patients Undergoing Maintenance Hemodialysis.

Authors:  Yoshifumi Abe; Atsuhiko Matsunaga; Ryota Matsuzawa; Toshiki Kutsuna; Shuhei Yamamoto; Kei Yoneki; Manae Harada; Ryoma Ishikawa; Takaaki Watanabe; Atsushi Yoshida
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

Review 7.  Inflammatory biomarkers as a part of diagnosis in diabetic peripheral neuropathy.

Authors:  Sai Laxmi M; Prabhakar O
Journal:  J Diabetes Metab Disord       Date:  2021-01-15

8.  Investigation of depression in Greek patients with diabetic peripheral neuropathy.

Authors:  Maria Rekleiti; Pavlos Sarafis; Maria Saridi; Aikaterini Toska; Chrysovaladis Melos; Kyriakos Souliotis; Maria Tsironi
Journal:  Glob J Health Sci       Date:  2013-06-16

9.  The Need for Improved Management of Painful Diabetic Neuropathy in Primary Care.

Authors:  Teresa Sobhy
Journal:  Pain Res Manag       Date:  2016-03-02       Impact factor: 3.037

10.  Feasibility and effectiveness of electrochemical dermal conductance measurement for the screening of diabetic neuropathy in primary care. DECODING Study (Dermal Electrochemical Conductance in Diabetic Neuropathy). Rationale and design.

Authors:  Juan J Cabré; Teresa Mur; Bernardo Costa; Francisco Barrio; Charo López-Moya; Ramon Sagarra; Montserrat García-Barco; Jesús Vizcaíno; Immaculada Bonaventura; Nicolau Ortiz; Gemma Flores-Mateo
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.